← Back to Search

Other

Danicamtiv Study in Healthy Adults

Phase 1
Waitlist Available
Research Sponsored by Bristol-Myers Squibb
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to day 43
Awards & highlights

Study Summary

This trial looks into how food affects how well a drug works in healthy adults.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to day 43
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to day 43 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Area under the plasma concentration time curve from time zero extrapolated to infinite time (AUC(INF))
Area under the plasma concentration time curve from time zero to the time of the last quantifiable concentration (AUC(0-T))
Maximum observed plasma concentration (Cmax)
Secondary outcome measures
Apparent total body clearance (CLT/F)
Apparent volume of distribution (Vz/F)
Number of participants with Adverse Events (AEs)
+7 more

Trial Design

3Treatment groups
Experimental Treatment
Group I: Treatment CExperimental Treatment1 Intervention
Group II: Treatment BExperimental Treatment1 Intervention
Group III: Treatment AExperimental Treatment1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Danicamtiv
2023
Completed Phase 1
~70

Find a Location

Logistics

Participation is compensated

You will be compensated for participating in this trial.

Who is running the clinical trial?

Bristol-Myers SquibbLead Sponsor
2,642 Previous Clinical Trials
4,130,102 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Has Treatment B been accorded the necessary regulatory approval?

"Since Treatment B is in its early Phase 1 of trials, there is limited evidence to support efficacy and safety, thus we assign it a score of 1."

Answered by AI

Are individuals under 70 years of age suitable participants for this experiment?

"This medical study is open to individuals that are of legal age (18 or above) and not yet elderly (65 or below)."

Answered by AI

Are there any slots available in this trial for participants?

"Yes, currently this trial is open for enrollment. The initial listing went live on September 5th 2023 and it was last revised on October 3rd of the same year."

Answered by AI

What is the aggregate figure of individuals engaging in this research?

"Confirmed. Clinical trials dot gov has the trial, which was posted on September 5th 2023, listed as actively recruiting. The research is hoping to find 21 participants from a single site."

Answered by AI

Am I eligible to become involved in this medical experiment?

"This medical trial seeks 21 healthy volunteers aged 18 to 65 who have a BMI between 18.0 kg/m2 and 30.0 km/m2, resting heart rate of at least 55 bpm, and seasonal allergies that do not necessitate treatment prior to the study commencement."

Answered by AI

Who else is applying?

What site did they apply to?
Anaheim Clinical Trials
What portion of applicants met pre-screening criteria?
Met criteria
Recent research and studies
clinicaltrials.govStudy
A Study to Assess the Relative Biological Availability and the Effect of Food on the Drug Levels of Danicamtiv in Healthy Adult Participants
2023. "A Study to Assess the Relative Biological Availability and the Effect of Food on the Drug Levels of Danicamtiv in Healthy Adult Participants". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06027437.
~13 spots leftby May 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top